Male obesity-associated secondary hypogonadism (MOSH) involves increased levels of leptin, insulin, proinflammatory cytokines, and estrogen, which contribute to functional hypogonadotropic hypogonadism.34 The gene discussed is INS; the disease is hypogonadotropic hypogonadism.